Answers are grounded in this paper and cite their sources.
This is the most comprehensive study reporting the expression of MCTs and CD147 in gliomas. The MCT1 inhibitor CHC exhibited anti-tumoral and anti-angiogenic activity in gliomas and, of importance, enhanced the effect of temozolomide. Thus, our results suggest that development of therapeutic approaches targeting MCT1 may be a promising strategy in glioblastoma treatment.
No takes yet. Share an insight, caveat, or question.
Miranda‐Gonçalves et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: